Knight Therapeutics Stock Investor Sentiment

KHTRF Stock  USD 4.17  0.05  1.18%   
Roughly 62% of Knight Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Knight Therapeutics pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Knight Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Knight Therapeutics stock news signals to limit their universe of possible portfolio assets.
Knight Therapeutics pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Knight daily returns and investor perception about the current price of Knight Therapeutics as well as its diversification or hedging effects on your existing portfolios.
  
over six months ago at news.google.com         
Knight Therapeutics Reports Second Quarter 2024 - GlobeNewswire
Google News at Macroaxis
over six months ago at news.google.com         
3 Top Canadian Pharmaceutical Stocks in July 2024 - Stocktrades.ca
Google News at Macroaxis
over six months ago at news.google.com         
GUDCT Stock Price, Quote News - BNN Bloomberg
Google News at Macroaxis
over six months ago at news.google.com         
Knight Therapeutics Inc. Senior Officer Sells C57,000.00 in Stock - American Banking and Market News
Google News at Macroaxis
over six months ago at news.google.com         
Knight Therapeutics Inc. Senior Officer Amal Khouri Sells 10,000 Shares of Stock - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Knight Announces Normal Course Issuer Bid - Financial Post
Google News at Macroaxis
over six months ago at news.google.com         
The CEO Director of Knight Therapeutics Inc. , Jonathan Goodman, Just Bought 6.3 percent More Shares...
Google News at Macroaxis
over six months ago at news.google.com         
Robert Nathaniel Lande Sells 20000 Shares of Knight Therapeutics Inc. Stock - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Knight Therapeutics Inc. Senior Officer Sells C116,022.00 in Stock - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Robert Nathaniel Lande Sells 15000 Shares of Knight Therapeutics Inc. Stock - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Closing Bell Knight Therapeutics Inc down on Friday - Barchart
Google News at Macroaxis
over six months ago at news.google.com         
Knight Therapeutics Reaches New 52-Week High at 6.17 - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Stifel Nicolaus Increases Knight Therapeutics Price Target to C5.75 - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Knight Therapeutics Reports First Quarter 2024 Results - GlobeNewswire
Google News at Macroaxis
over six months ago at news.google.com         
Knight Therapeutics Inc. announces voting results from the Annual General Meeting - Yahoo Finance
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Knight Therapeutics that are available to investors today. That information is available publicly through Knight media outlets and privately through word of mouth or via Knight internal channels. However, regardless of the origin, that massive amount of Knight data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Knight Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Knight Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Knight Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Knight Therapeutics alpha.

Knight Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Knight Pink Sheet analysis

When running Knight Therapeutics' price analysis, check to measure Knight Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Knight Therapeutics is operating at the current time. Most of Knight Therapeutics' value examination focuses on studying past and present price action to predict the probability of Knight Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Knight Therapeutics' price. Additionally, you may evaluate how the addition of Knight Therapeutics to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Transaction History
View history of all your transactions and understand their impact on performance